Fresenius Helixone  FX-8 Low Flux Dialyzer – for Hemodialysis

Shipping time and rates

Shipping about 5-7 days

Fresenius Helixone FX-8 Low Flux Dialyzer – for Hemodialysis

New

Specifications

  • Dialyzer Type : Low-flux, hollow fiber
  • Membrane Material : Helixone® (polysulfone)
  • Effective Surface Area : 1.4 m²
  • Priming/Blood Volume : ~74 mL
  • Ultrafiltration Coefficient (KUF) : 12 mL/h/mmHg
  • Blood Flow Range (Qb) : ~150–400 mL/min
  • Dialysate Flow (Qd) : ~500 mL/min (standard test condition)
  • Sterilization Method : INLINE steam sterilized
  • Housing Material : Polypropylene
  • Potting Material : Polyurethane
  • Flux Type : Low-flux
  • Application : Hemodialysis (HD)

highlights

  • Nanotechnology-based membrane (NCS™) → uniform pore size and improved efficiency
  • Homogeneous blood flow design reduces stagnation zones and improves performance
  • Reduced diffusion resistance due to optimized fiber dimensions
  • Dry, sterile dialyzer with minimal contamination risk (steam sterilized)
  • Consistent and reliable dialysis outcomes across treatments

in the box

  • 1 × FX-8 Low Flux Dialyzer (sterile, single-use)

Use Cases :

  • Chronic hemodialysis (HD)
  • Acute kidney injury (AKI) dialysis
  • Routine low-flux dialysis therapy
  • Suitable for patients requiring controlled ultrafiltration and small-solute clearance

Key Features :

  • Helixone® membrane technology with controlled pore structure for efficient toxin removal
  • Low-flux design optimized for removal of small molecules (urea, creatinine)
  • Advanced fiber bundle geometry for improved hemodynamics and solute clearance
  • Radial dialysate flow design ensures uniform distribution around fibers
  • INLINE steam sterilization (no chemical residues, high purity)
  • Lightweight polypropylene housing for easier handling and disposal
  • High biocompatibility & endotoxin retention

Warranty

Seller

AA MEDIE QUIPLearn More

Product Description

The FX-8 is a single-use, low-flux hollow-fiber dialyzer designed for hemodialysis treatment in patients with renal failure. It uses the advanced Helixone® polysulfone membrane, developed using nanotechnology to provide efficient removal of uremic toxins while maintaining high biocompatibility. The ...

Other Details

Loading...